Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis

Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis

Background: The use of BAL to study ILDs has improved our understanding of IPF pathogenesis. BAL fluid is routinely collected and can be considered a clinical and research tool. The procedure is well tolerated and minimally invasive. No specific cell lines from BAL or immortalized cell lines from IP...

Full description

Bibliographic Details
Main Authors:	Laura Bergantini, Miriana d’Alessandro, Sara Gangi, Dalila Cavallaro, Giuseppe Campiani, Stefania Butini, Claudia Landi, Luca Bini, Paolo Cameli, Elena Bargagli
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Cells
Subjects:	BAL fibroblast IPF
Online Access:	https://www.mdpi.com/2073-4409/11/9/1441

Similar Items

Bronchoalveolar-Lavage-Derived Fibroblast Cell Lines Provide Tools for Investigating Various Interstitial Lung Diseases
by: Siri Lehtonen, et al.
Published: (2022-07-01)

SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
by: Ivan GUR, et al.
Published: (2024-01-01)

CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients
by: Miriana d’Alessandro, et al.
Published: (2022-05-01)

Effect of Hypoxia in the Transcriptomic Profile of Lung Fibroblasts from Idiopathic Pulmonary Fibrosis
by: Yair Romero, et al.
Published: (2022-09-01)

Bronchoalveolar Lavage Cytology in Severe Equine Asthma: Cytocentrifugated versus Sediment Smear Preparations
by: Maria Morini, et al.
Published: (2023-08-01)

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach
by: Miriana d’Alessandro, et al.
Published: (2021-04-01)

Clinical evaluation of the Simplexa HSV 1 & 2 Direct assay for bronchoalveolar lavage specimens
by: Tung Phan, et al.
Published: (2024-06-01)

Molecular Detection of Pneumocystis jirovecii in the Bronchoalveolar Lavage Samples in Patients with Various Pulmonary Disorders(Original Article)
by: Narges Chitsaz, et al.
Published: (2023-12-01)

Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis
by: Piera Soccio, et al.
Published: (2024-01-01)

Co-culture of human AT2 cells with fibroblasts reveals a MUC5B phenotype: insights from an organoid model
by: Yiwen Yao, et al.
Published: (2024-11-01)

A simplified method for bronchoalveolar lavage in mice by orotracheal intubation avoiding tracheotomy
by: Bruno Luckow, et al.
Published: (2021-10-01)

The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis
by: Philomène Lavis, et al.
Published: (2024-09-01)

DNA Methylation Demonstrates Bronchoalveolar Cell Senescence in People Living with HIV: An Observational Cohort Study
by: Ana I. Hernandez Cordero, et al.
Published: (2024-06-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
by: Laura Bergantini, et al.
Published: (2021-11-01)

Altered Extracellular Vesicle-Derived Protein and microRNA Signatures in Bronchoalveolar Lavage Fluid from Patients with Chronic Obstructive Pulmonary Disease
by: Sabine Bartel, et al.
Published: (2024-05-01)

Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2024-03-01)

Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease
by: Maria Angela Licata, et al.
Published: (2024-12-01)

Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients
by: Maura D’Amato, et al.
Published: (2022-05-01)

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
by: Annapaola Mariniello, et al.
Published: (2022-10-01)

CMH-Small Molecule Docks into SIRT1, Elicits Human IPF-Lung Fibroblast Cell Death, Inhibits Ku70-deacetylation, FLIP and Experimental Pulmonary Fibrosis
by: Jenya Konikov-Rozenman, et al.
Published: (2020-07-01)

An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)
by: Mark H. Gotfried, et al.
Published: (2018-06-01)

Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients
by: Noriko Ouji-Sageshima, et al.
Published: (2024-12-01)

Histologic Analysis of Idiopathic Pulmonary Fibrosis by Morphometric and Fractal Analysis
by: Massimiliano Mancini, et al.
Published: (2023-05-01)

The importance of bronciıoalveolar lavage fluid examinations in the diagnosis of respiratory tract diseases in calves
by: Fatih Mehmet Birdane, et al.

Immunological Pathways in Sarcoidosis and Autoimmune Rheumatic Disorders—Similarities and Differences in an Italian Prospective Real-Life Preliminary Study
by: Miriana d’Alessandro, et al.
Published: (2023-05-01)

Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis
by: Philomène Lavis, et al.
Published: (2023-10-01)

Momentousness of integration of the high-resolution computed tomography scoring systems with pulmonary artery systolic pressure measurement for inference of idiopathic pulmonary fibrosis severity
by: Sara Mahmoud Ragaee, et al.
Published: (2024-08-01)

Murine Bronchoalveolar Lavage
by: Fan Sun, et al.
Published: (2017-05-01)

Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysis
by: Daisuke Kawahara, et al.
Published: (2022-12-01)

Absence of HDAC3 by Matrix Stiffness Promotes Chromatin Remodeling and Fibroblast Activation in Idiopathic Pulmonary Fibrosis
by: Fernanda Toscano-Marquez, et al.
Published: (2023-03-01)

Investigates the Role of PANoptosis in Idiopathic Pulmonary Fibrosis and Potential Therapeutic Targets
by: Xiang Y, et al.
Published: (2024-12-01)

Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction
by: Pasquale Tondo, et al.
Published: (2025-01-01)

Functional Repercussions of Hypoxia-Inducible Factor-2α in Idiopathic Pulmonary Fibrosis
by: Ana Karen Torres-Soria, et al.
Published: (2022-09-01)

Trichomonads in bronchoalveolar lavage fluid
by: Lizhi Yan, et al.
Published: (2025-03-01)

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
by: Paola Confalonieri, et al.
Published: (2022-06-01)

Higher body mass index was associated with a lower mortality of idiopathic pulmonary fibrosis: a meta-analysis
by: Dengyun Pan, et al.
Published: (2024-08-01)

Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary Fibrosis
by: Yu Cui, et al.
Published: (2021-02-01)

Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study
by: Kathrin Rothe, et al.
Published: (2023-03-01)

Galactomannan Antigen Assay for the Diagnosis of Invasive Aspergillosis: A Study from a Tertiary Care Hospital of Central India
by: Archana Keche, et al.
Published: (2024-06-01)